When Takeda CEO Christophe Weber retires from the company in June 2026, a familiar face among the Massachusetts biotech scene will take over leading the Japanese pharma giant.
A fast-casual restaurant that serves Korean and Mexican food has received approval to open on Route 9 in Framingham.
U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...
The Trump administration is poised to supercharge America’s appetite for supplements.
MassDOT has launched a new Naloxone pilot program, starting with two locations in Boston and one in Springfield.